|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 487/04 | (2006.01) |
| A61K 31/52 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3091020 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16159438.7 |
| Date of filing the European patent application | 2010-05-13 | |
| (97) | Date of publication of the European application | 2016-11-09 |
| (45) | Date of publication and mention of the grant of the patent | 2020-12-30 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 216221 P | 2009-05-14 | US |
| (72) |
Armitage, Ian, G, US
Chopra, Reenu, GB
Cooper, Martin, Ian, GB
Langston, Marianne, US
Langston, Steven P., US
Vyskocil, Stepan, US
|
| (73) |
Takeda Pharmaceutical Company Limited ,
1-1, Doshomachi 4-chome,
Chuo-ku,, Osaka-shi, Osaka,
JP
|
| (54) | HYDROCHLORIDE SALT OF ((1S,2S,4R)-4-{4-[(1S)-2,3-DIHYDRO-1H-INDEN-1-YLAMINO]-7H-PYRROLO[2,3-D]PYRIMIDIN-7-YL}-2-HYDROXYCYCLOPENTYL)METHYL SULFAMATE |
| HYDROCHLORIDE SALT OF ((1S,2S,4R)-4-{4-[(1S)-2,3-DIHYDRO-1H-INDEN-1-YLAMINO]-7H-PYRROLO[2,3-D]PYRIMIDIN-7-YL}-2-HYDROXYCYCLOPENTYL)METHYL SULFAMATE |